Chemotherapeutic drug scavenger-based combination therapy toward treating triple-negative breast cancer

Chemotherapeutic drug scavenger-based combination therapy toward treating triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is resistant to most antitumor treatments, leaving chemotherapy as the primary option. Although doxorubicin (Dox) in combination with other therapies is promising for TNBC management, the combined effect is still compromised by the dose-limiting toxiciti...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingqing Yin, Yutong Zhong, Mengchun Chen, Weian Mao, Yuan Yang, Li Li, Dongyan Tian, Shuangshuang Liu, Ying Chen, Jiale Quan, Shiyu Li, Deli Zhuge, Xufei Zhang, Ledan Wang, Fang Wang, Yiming Chen, Xiaosheng Lu, Xiaoji Lin, Yijie Chen, Linzhi Yan
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Nanobiotechnology
Subjects:
Triple-negative breast cancer
Chemotherapeutic drug
Detoxification
Biomimetic
Combination therapy
Online Access:https://doi.org/10.1186/s12951-025-03571-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12951-025-03571-z

Similar Items